BSE Live
Mar 09, 16:01Prev. Close
4847.60
Open Price
4781.05
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Mar 09, 15:56Prev. Close
4849.50
Open Price
4790.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
4769.50 (20)
| Key Financial Ratios of Pfizer (in Rs. Cr.) | Nov 09 | Nov 08 | Nov 07 | Nov 06 | Nov 05 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 45.87 | 100.23 | 113.57 | 35.43 | 22.73 | |
| Diluted EPS (Rs.) | 45.87 | 100.23 | 113.57 | 35.43 | 22.73 | |
| Cash EPS (Rs.) | 48.64 | 103.96 | 116.78 | 39.81 | 27.37 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 333.19 | 301.43 | 217.35 | 147.36 | 126.18 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 333.19 | 301.43 | 217.35 | 147.36 | 126.18 | |
| Dividend / Share(Rs.) | 12.50 | 12.50 | 27.50 | 12.50 | 10.00 | |
| Revenue from Operations/Share (Rs.) | 278.47 | 244.28 | 245.05 | 244.26 | 221.45 | |
| PBDIT/Share (Rs.) | 72.26 | 71.85 | 153.51 | 58.69 | 41.30 | |
| PBIT/Share (Rs.) | 69.48 | 68.13 | 150.30 | 54.31 | 36.66 | |
| PBT/Share (Rs.) | 69.48 | 68.13 | 150.29 | 54.29 | 36.61 | |
| Net Profit/Share (Rs.) | 45.87 | 100.23 | 113.57 | 35.43 | 22.73 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 25.94 | 29.41 | 62.64 | 24.02 | 18.64 | |
| PBIT Margin (%) | 24.95 | 27.88 | 61.33 | 22.23 | 16.55 | |
| PBT Margin (%) | 24.95 | 27.88 | 61.33 | 22.22 | 16.53 | |
| Net Profit Margin (%) | 16.47 | 41.03 | 46.34 | 14.50 | 10.26 | |
| Return on Networth / Equity (%) | 13.76 | 33.25 | 52.25 | 24.04 | 18.01 | |
| Return on Capital Employed (%) | 13.71 | 33.14 | 51.89 | 23.91 | 17.77 | |
| Return on Assets (%) | 11.33 | 16.35 | 38.76 | 16.22 | 11.62 | |
| Total Debt/Equity (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Asset Turnover Ratio (%) | 68.83 | 39.85 | 83.63 | 111.90 | 113.25 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 5.18 | 1.85 | 3.52 | 2.61 | 2.24 | |
| Quick Ratio (X) | 4.63 | 1.72 | 3.09 | 2.14 | 1.79 | |
| Inventory Turnover Ratio (X) | 7.33 | 5.85 | 7.69 | 7.40 | 7.36 | |
| Dividend Payout Ratio (NP) (%) | 27.25 | 12.47 | 24.21 | 35.28 | 43.99 | |
| Dividend Payout Ratio (CP) (%) | 25.69 | 12.02 | 23.54 | 31.39 | 36.53 | |
| Earnings Retention Ratio (%) | 72.75 | 87.53 | 75.79 | 64.72 | 56.01 | |
| Cash Earnings Retention Ratio (%) | 74.31 | 87.98 | 76.46 | 68.61 | 63.47 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 2,319.04 | 851.96 | 1,451.96 | 2,004.40 | 2,475.06 | |
| EV/Net Operating Revenue (X) | 2.79 | 1.17 | 1.99 | 2.75 | 3.75 | |
| EV/EBITDA (X) | 10.75 | 3.97 | 3.17 | 11.44 | 20.08 | |
| MarketCap/Net Operating Revenue (X) | 3.43 | 1.91 | 2.64 | 3.17 | 4.06 | |
| Retention Ratios (%) | 72.74 | 87.52 | 75.78 | 64.71 | 56.00 | |
| Price/BV (X) | 2.86 | 1.55 | 2.98 | 5.25 | 7.13 | |
| Price/Net Operating Revenue | 3.43 | 1.91 | 2.64 | 3.17 | 4.06 | |
| Earnings Yield | 0.05 | 0.21 | 0.18 | 0.05 | 0.03 |
10.02.2026
Pfizer Standalone December 2025 Net Sales at Rs 645.03 crore, up 19.9% Y-o-Y
13.11.2025
Pfizer Standalone September 2025 Net Sales at Rs 642.34 crore, up 9.13% Y-o-Y
20.05.2025
Pfizer Standalone March 2025 Net Sales at Rs 591.91 crore, up 8.28% Y-o-Y
01.02.2025
Pfizer Standalone December 2024 Net Sales at Rs 537.99 crore, down 0.37% Y-o-Y
19.10.2016
05.08.2016
03.01.2014
10.01.2011